share_log

NovAccess Global Inc. (OTCMKTS:XSNX) Short Interest Up 97.4% in October

NovAccess Global Inc. (OTCMKTS:XSNX) Short Interest Up 97.4% in October

NovAccess Global Inc.(场外交易代码:XSNX)空头股数10月份上涨97.4%
Defense World ·  2022/11/12 14:11

NovAccess Global Inc. (OTCMKTS:XSNX – Get Rating) was the recipient of a significant growth in short interest in October. As of October 31st, there was short interest totalling 7,700 shares, a growth of 97.4% from the October 15th total of 3,900 shares. Based on an average daily volume of 9,100 shares, the days-to-cover ratio is presently 0.8 days.

NovAccess Global Inc.(场外交易代码:XSNX-GET Rating)是10月份空头股数大幅增长的接受者。截至10月31日,空头股数共有7700股,比10月15日的3900股增长了97.4%。以日均成交量9,100股计算,目前天数与回补比率为0.8天。

NovAccess Global Stock Performance

NovAccess全球股票表现

Shares of XSNX opened at $0.20 on Friday. NovAccess Global has a 12 month low of $0.10 and a 12 month high of $0.60. The company's fifty day moving average is $0.18 and its 200-day moving average is $0.21.

上周五,XSNX的股价开盘报0.20美元。NovAccess Global的12个月低点为0.10美元,12个月高位为0.60美元。该公司的50日移动均线切入位在0.18美元,200日移动均线切入位在0.21美元。

Get
到达
NovAccess Global
NovAccess全球
alerts:
警报:

About NovAccess Global

关于NovAccess Global

(Get Rating)

(获取评级)

NovAccess Global Inc, a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc was incorporated in 1997 and is headquartered in Chesterland, Ohio.
NovAccess Global Inc是一家生物制药公司,该公司开发新型免疫疗法来治疗美国的脑瘤患者。该公司专门从事与利用患者免疫系统攻击癌症相关的尖端研究。NovAccess Global Inc.成立于1997年,总部设在俄亥俄州切斯特兰。

See Also

另请参阅

  • Get a free copy of the StockNews.com research report on NovAccess Global (XSNX)
  • MarketBeat: Week in Review 11/7 – 11/11
  • Oil Is a Compelling Reason The Sell-Off In Stocks Isn't Over
  • Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
  • Six Flags is a Ride You Don't Want to Get Stuck On
  • Hanesbrands May be Signaling a Bad Week for Retail Stocks
  • 免费获取NovAccess Global(XSNX)上的StockNews.com研究报告
  • MarketBeat:回顾中的一周11/7-11/11
  • 油价是股市抛售尚未结束的一个令人信服的原因
  • 中盘Neurocrine生物科学是井喷后的第三季度报告吗?
  • 六面旗帜是一种你不想被困住的旅程
  • Hanesbrand可能发出零售类股本周表现不佳的信号

Receive News & Ratings for NovAccess Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovAccess Global and related companies with MarketBeat.com's FREE daily email newsletter.

接受NovAccess全球日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对NovAccess Global和相关公司的最新新闻和分析师评级的每日简要摘要。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发